Navigation Links
Laboratory Heart valve to study Heart diseases

Researcher Grande-Allen is developing a laboratory heart valve which could be used in testing the action of drugs on heart valves in an invitro model. // This new bioreactor heart valve would help in breaking the etiology behind the cause of heart valve disease.

Research on the laboratory heart valve is funded with $750,000 from NIH and the researchers have found the difference in biochemical and alterations in heart valves between normal and heart disease humans and the researchers developed these laboratory valves with the help of using Pig valves and the researchers are planning to study the efficacy of new drugs developed for treating heart disease with the help of this laboratory heart valve and they are to test how the valves reacts to different biochemical alterations, their flexibility and texture modifications which would help to find new insights in heart disease research. Researchers have published the results of their initial study in Journal of the American College of Cardiology.


'"/>




Page: 1

Related medicine news :

1. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
2. Laboratory grown vegetarian meat
3. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
4. NCFAD Nominated As Reference Laboratory for Bird Flu and BSE
5. British Laboratory Certifies Coke as Safe
6. India to Set Up Nicotine-Mapping Laboratory
7. A Laboratory Filtration System Kills 100 Percent Of Dangerous Microbes In Water
8. Erroneous Laboratory Operation May Lead To a Cancer Drug
9. One in Three Heart Attack Patients Have No Chest Pains
10. Epileptic Seizures Can Be Due to Heart Problem
11. Bypass Heart Surgery Performed Without General Anesthesia
Post Your Comments:
(Date:5/16/2008)...National HIV Vaccine Awareness Day, May,18, WASHI...x years into the,AIDS epidemic, someone is newly i...unday, May 18, HIV Vaccine Awareness Day, AIDS Act... Institute of Allergy and Infectious,Disease (NIAI...s everyone,to help end the AIDS epidemic by partic...
(Date:5/16/2008)...untsworth plc (LSE: HNT), "the Group",a leading i...nications,group headquartered in London, released ...Group,s performance in the first quarter 2008 (the...follows below., 15 May 2008, ...erim Management Statement, Record net ...
(Date:5/16/2008)... More in 2007, WASHINGTON, May 16 /PRNewswire-USN...cancer deaths, the National Cancer Institute (NCI)...in lung cancer research in 2007,according to upda...) today., The two other federal agencies with sig...isease Control and Prevention (CDC) and the,Depart...
(Date:5/16/2008)...Comprehensive Income increased 42% to $9.7 million... - 2007 Gross Margin of 76%, - Product Sales Back... million from $2.4 million as of December 31, 200...stCall/ -- Huiheng,Medical, Inc. ("Huiheng" or the...sed leader in the development, sales and support o...
Breaking Medicine News(10 mins):Health News:AIDS Action Urges Everyone to Help End the AIDS Epidemic by Being Part of the Search for an HIV Vaccine 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 4Health News:Lung Cancer Still Lowest in Federal Funding 2Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 2Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 3Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 4Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 5Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 6
...al neuroscientist of Vanderbilt University have de...n insight into neural circuits that play a role in... circuits that make us apply previously learned ru...-control. The researchers feel that the new use o...
... and recovery from exercise may be a successful pr...nd vagal activities balance the changes in heart r...s from France, who carried out the research to fin...udden deaths, are of the opinion that sudden death...
...d at Digestive Disease Week 2005, antidepressants ...Clinical depression, also known as unipolar depres...ike selective serotonin reuptake inhibitors (SSRIs...s research have shown that use of nonsteroidal ant...
...d a set of cells in the pancreas that are targeted...e 1. The researchers from University of Colorado a...earch is likely to change the study of diabetes au...nge the way other autoimmune diseases are studied....
Other Medicine News:
(Date:5/15/2008)...May 15 /- Cytopia Limited,(...s upcoming oral,presentation on CYT997 at the 2008...l Oncology (ASCO) will be accessible to the public...pm on Thursday 15 May (US EDT)., The oral present...ovel,cytotoxic and vascular disrupting agent, in p...
(Date:5/15/2008)...15 /- Schering-Plough,Corpo...ience and treatment of,chronic hepatitis C virus (...eral clinical studies with PEGINTRON(TM) (peginter...bination therapy, as well as boceprevir, the,compa...will be presented at,the 39th annual Digestive Dis...
(Date:5/15/2008)... 15 /- Sanofi-aventis,(EURO...ings from the,landmark ATHENA study showed Multaq(...tment of patients with atrial fibrillation or atri...ospitalizations or death from any,cause by a stati...he study,primary endpoint. The ATHENA results will...
(Date:5/15/2008)...OULOUSE, France, May 15 /- Cerenis,Th...utical company,developing HDL-related compounds fo...seases, today announced that it has completed a Ph...ny,s lead product candidates.,CER-002 is a peroxis...pecific agonist in development for the treatment o...
Breaking Medicine Technology:Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 2Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 3Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 4Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 5Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 6Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 7Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease 2USC researchers identify mechanism that controls activation of stem cells during hair regeneration 1926 1USC researchers identify mechanism that controls activation of stem cells during hair regeneration 1926 2Healthcare M 26A Activity on the Rise 9649 1Healthcare M 26A Activity on the Rise 9649 2Women May Enjoy Boost of Heart Health With Soy 9647 1Women May Enjoy Boost of Heart Health With Soy 9647 2Internet Comes to Rescue of 14 Million Uninsured in U S 3B Providing Access to Gov Health Programs Theyre Not Aware of 9645 1Internet Comes to Rescue of 14 Million Uninsured in U S 3B Providing Access to Gov Health Programs Theyre Not Aware of 9645 2Internet Comes to Rescue of 14 Million Uninsured in U S 3B Providing Access to Gov Health Programs Theyre Not Aware of 9645 3
...re-FirstCall/ --,Schering-Plough Corporation annou...ts novel oral thrombin receptor antagonist (TRA),S...entific Sessions,of the of Cardiology (ACC.07)/Inn...n New Orleans. The Phase II trial, referred to,as ...oronary,Intervention (TRA-PCI) trial, has been acc...
...an TNFa, LAUSANNE, Switzerland, March 12, 2007 /PR...al independent biopharmaceutical,development compa...nditions, announces the presentation of preclinica... Debio-0512 as an anti-TNFa,therapeutic vaccine, t...ls of acute and chronic inflammation. Debio-0512 i...
Other Medicine Technology:Schering-Plough Announces Presentation of Phase II Trial Results,for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual,Meeting of The American College of Cardiology/i2 Summit 2Preclinical Update - Debio-0512 Therapeutic Vaccine for the,Treatment of Chronic and Acute Inflammatory Conditions 2
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve
...ecial order products are offered as 1-piece or mod...r instruments may be customized with handles of ch...n and flush ports. Many standard patterns are avai... may affect delivery times. , Please Note: Indiv...
...ecial order products are offered as 1-piece or mod...r instruments may be customized with handles of ch...n and flush ports. Many standard patterns are avai... may affect delivery times. , Please Note: Indiv...
Medicine Products: